We sequence proteins. Glyphic Biotechnologies is a biotechnology startup revolutionizing the field of proteomics. While DNA can reveal biological insights, proteins actually tell us what our bodies will do. We are developing a first-of-its-kind, next-generation protein sequencing platform to enable researchers to gain novel insights into biology and disease.



New York, NY, USA

Glyphic Biotechnologies

Cantos Ventures is a pre-seed and seed-stage venture capital fund that invests in startups in 'pre-inflection' industries. We view every startup as a journey, and seek to join those with noble aims.

Your story awaits